About this trial
Gastroparesis is defined by objective delaying of gastric emptying without any evidence of mechanical obstruction. Diabetic gastroparesis is a potential complication that occurs in the setting of poorly controlled diabetes, resulting from dysfunction in the coordination and function of the autonomic nervous system, neurons, and specialized pacemaker cells (interstitial cells of Cajal, ICC) of the stomach and intestine, and the smooth muscle cells of the gastrointestinal tract
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Type 2 DM
Age < 40 years
>5 years of DM
Disqualifiers
Type 1 DM
History of GIT surgry
Medical disease affect gastric emptying
Using of prokinetic
Trial population
type2 diabetic patient in assiut university hospital
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
prevalence of gastroparesis in type 2 diabetic patients
Secondary outcomes
Value of nuclear imaging (Gastric emptying scintigraphy) in diagnosis of gastroparesis
using of Gastric emptying scintigraphy as a tool for diagnosis of gastroparesis
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: